Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafine-thymol silicone gel versus terbinafine cream for tinea corporis
IRCT20240923063136N3Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in tinea corporis and dermatophytosis comparing Silicone gel containing terbinafine and thymol with Terbinafine cream control (2 arms). Primary endpoints: Mycological symptoms, Erythema at infected area and 2 more. Started Oct 2025; status: completed.
02
Drugs
Terbinafinethymol
03
Conditions
tinea corporisdermatophytosis
Beyond the preview
Go deeper on IRCT20240923063136N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240923063136N3.